Balance Sheet ALCONIX Corporation

Stocks

3036

JP3126210008

Specialty Mining & Metals

Delayed Japan Exchange 21:33:06 2026-08-24 EDT			5-day change	1st Jan Change
3,470.00 ^JPY	+0.14%		-4.01%	+37.86%

08-04	Alconix Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI
08-04	Alconix Corporation Revises Dividend Guidance for the Second Quarter-End and Fiscal Year Ending March 31, 2027	CI

df103d251cd704ce7caaafea83.ecVzqzhfnl61pYenSZV5a0gSq2rdR2rdBtAhL-9L5Jw.Gp8y_Q5t6Wrg-vXsGdArCg8k-x2qP1PsQLJlXtYInOUhgwfoSAz4BOHwvw

Published financial data: ALCONIX CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	156B	178B	175B	197B	220B
Total Revenues	156B	178B	175B	197B	220B
Cost of Goods Sold, Total	131B	153B	152B	171B	189B
Gross Profit	25.77B	25.08B	22.92B	26.02B	30.63B
Selling General & Admin Expenses, Total	13.32B	16.62B	17.5B	19.1B	20.78B
Provision for Bad Debts	-115M	62M	-41M	-3M	106M
Depreciation & Amortization - (IS)	905M	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	640M	-	-	-	-
Other Operating Expenses, Total	14.75B	16.68B	17.46B	19.1B	20.88B
Operating Income	11.02B	8.39B	5.46B	6.92B	9.74B
Interest Expense, Total	-519M	-840M	-1.1B	-973M	-1.05B
Interest And Investment Income	489M	509M	817M	717M	507M
Net Interest Expenses	-30M	-331M	-282M	-256M	-541M
Income (Loss) On Equity Invest.	4M	-	-	-	-
Currency Exchange Gains (Loss)	-87M	55M	4M	328M	-245M
Other Non Operating Income (Expenses)	99M	57M	259M	536M	437M
EBT, Excl. Unusual Items	11.01B	8.18B	5.44B	7.53B	9.4B
Gain (Loss) On Sale Of Investments	225M	430M	414M	1.15B	1.82B
Gain (Loss) On Sale Of Assets	8M	81M	35M	-	1.34B
Asset Writedown	-105M	-243M	-	-	-449M
Legal Settlements	-	-	-	-	-
Other Unusual Items	28M	29M	-2.07B	-1.17B	-1.51B
EBT, Incl. Unusual Items	11.16B	8.47B	3.82B	7.5B	10.6B
Income Tax Expense	3.57B	2.93B	2.18B	2.63B	4.93B
Earnings From Continuing Operations	7.6B	5.54B	1.65B	4.87B	5.67B
Net Income to Company	7.6B	5.54B	1.65B	4.87B	5.67B
Minority Interest	-88M	-50M	-52M	-68M	-75M
Net Income - (IS)	7.51B	5.49B	1.6B	4.8B	5.6B
Net Income to Common Incl Extra Items	7.51B	5.49B	1.6B	4.8B	5.6B
Net Income to Common Excl. Extra Items	7.51B	5.49B	1.6B	4.8B	5.6B
Per Share Items
Net EPS - Basic	282.52	182.37	53.04	159.3	186.57
Basic EPS - Continuing Operations	282.52	182.37	53.04	159.3	186.57
Basic Weighted Average Shares Outstanding	26.57M	30.09M	30.13M	30.16M	30M
Net EPS - Diluted	282.5	182.37	53.04	159.3	186.4
Diluted EPS - Continuing Operations	282.5	182.37	53.04	159.3	186.4
Diluted Weighted Average Shares Outstanding	26.58M	30.09M	30.13M	30.16M	30.03M
Normalized Basic EPS	255.58	168.12	111.24	153.73	193.2
Normalized Diluted EPS	255.55	168.12	111.24	153.73	193.01
Dividend Per Share	52	54	55	74	87
Payout Ratio	15.12	29.72	104.07	37.88	45.66
Supplemental Items
EBITDA	15.16B	13.24B	10.25B	11.73B	14.52B
EBITA	11.66B	9.27B	5.8B	7.26B	10.11B
EBIT	11.02B	8.39B	5.46B	6.92B	9.74B
EBITDAR	15.67B	-	-	-	-
Effective Tax Rate - (Ratio)	31.96	34.63	56.86	35.07	46.48
Normalized Net Income	6.79B	5.06B	3.35B	4.64B	5.8B
Non-Cash Pension Expense	352M	413M	429M	393M	315M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	255M	348M	338M	361M	394M
Net Rental Expense, Total	513M	-	-	-	-
Imputed Operating Lease Interest Expense	35.23M	-	-	-	-
Imputed Operating Lease Depreciation	478M	-	-	-	-

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	26.69B	26.99B	21.47B	18.76B	21.54B
Total Cash And Short Term Investments	26.69B	26.99B	21.47B	18.76B	21.54B
Accounts Receivable, Total	58.77B	61.68B	56.16B	62.4B	67.62B
Total Receivables	58.77B	61.68B	56.16B	62.4B	67.62B
Inventory	43.66B	49.4B	49.22B	56.5B	66.98B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	5.99B	6.14B	5.7B	6.71B	6.16B
Total Current Assets	135B	144B	133B	144B	162B
Net Property Plant And Equipment	25.06B	31.99B	31.74B	37.37B	39.4B
Long-term Investments	11.18B	11.48B	15.06B	11.15B	17.69B
Goodwill	1.89B	1.36B	1.02B	907M	672M
Other Intangibles, Total	2.82B	2.4B	2.07B	2.09B	1.98B
Loans Receivable Long-Term	22M	23M	20M	-	-
Deferred Tax Assets Long-Term	346M	423M	436M	740M	395M
Other Long-Term Assets, Total	1M	1M	1M	2M	2M
Total Assets	176B	192B	183B	197B	222B
Liabilities
Accounts Payable, Total	43.41B	40.91B	44.77B	53.38B	60.05B
Accrued Expenses, Total	1.24B	1.26B	1.38B	1.57B	1.94B
Short-term Borrowings	36.59B	45.76B	30.72B	32.65B	41.55B
Current Portion of Long-Term Debt	6.36B	5.16B	6.15B	5.94B	5.25B
Current Income Taxes Payable	2.68B	1.64B	1.54B	2.43B	2.94B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	4.36B	5.62B	5.14B	7.23B	8.7B
Total Current Liabilities	94.64B	100B	89.69B	103B	120B
Long-Term Debt	18.85B	20.9B	18.33B	15.15B	13.47B
Pension & Other Post Retirement Benefits	1.44B	1.38B	1.46B	1.25B	1.23B
Deferred Tax Liability Non Current	2.9B	3.23B	3.49B	3.31B	6.02B
Other Non Current Liabilities	1.27B	2.99B	3.57B	3.41B	1.32B
Total Liabilities	119B	129B	117B	126B	142B
Common Stock, Total	5.79B	5.81B	5.83B	5.85B	5.91B
Additional Paid In Capital	5.24B	5.27B	5.29B	5.39B	5.44B
Retained Earnings	40.56B	44.4B	44.33B	47.31B	50.35B
Treasury Stock	-1.16B	-1.16B	-1.15B	-1.56B	-1.46B
Comprehensive Income and Other	6.44B	8.2B	11.45B	12.72B	19.02B
Total Common Equity	56.87B	62.52B	65.75B	69.7B	79.26B
Minority Interest	462M	523M	601M	610M	684M
Total Equity	57.33B	63.05B	66.35B	70.31B	79.94B
Total Liabilities And Equity	176B	192B	183B	197B	222B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	30.07M	30.11M	30.14M	29.93M	30.06M
ECS Total Common Shares Outstanding	30.07M	30.11M	30.14M	29.93M	30.06M
Book Value / Share	1.89K	2.08K	2.18K	2.33K	2.64K
Tangible Book Value	52.16B	58.77B	62.66B	66.7B	76.61B
Tangible Book Value Per Share	1.73K	1.95K	2.08K	2.23K	2.55K
Total Debt	61.8B	71.82B	55.2B	53.74B	60.27B
Net Debt	35.11B	44.83B	33.73B	34.98B	38.74B
Debt Equivalent of Unfunded Proj. Benefit Obligation	994M	1.08B	1.12B	901M	872M
Debt Equivalent Oper. Leases	4.1B	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	462M	523M	601M	610M	684M
Inventories - Raw Materials, Total	3.64B	4.28B	3.79B	4.59B	4.48B
Inventories - Work In Process, Total	4.05B	4.07B	4.76B	5.61B	7.7B
Inventories - Finished Goods, Total	35.97B	41.05B	40.68B	46.29B	54.79B
Full Time Employees	2.93K	3.18K	3.23K	3.25K	3.1K
Accumulated Allowance for Doubtful Accounts (Supple)	642M	804M	838M	886M	404M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	11.16B	8.47B	3.83B	7.5B	10.6B
Depreciation & Amortization - CF	3.49B	3.98B	4.45B	4.48B	4.4B
Amortization of Goodwill and Intangible Assets - (CF)	640M	874M	337M	335M	370M
Depreciation & Amortization, Total	4.13B	4.85B	4.79B	4.81B	4.78B
(Gain) Loss From Sale Of Asset	76M	-	-	-	-1.32B
(Gain) Loss on Sale of Investments - (CF)	-225M	-84M	-342M	-1.01B	-1.78B
(Income) Loss On Equity Investments - (CF)	-4M	-	-	-	-
Other Operating Activities, Total	-2.03B	-5.02B	-2.68B	-1.87B	-3.72B
Change In Accounts Receivable	-7.57B	-10M	3.45B	-4.47B	-4.16B
Change In Inventories	-16.28B	-3.92B	937M	-6.2B	-10.28B
Change In Accounts Payable	7.16B	-4.54B	2.9B	7.46B	6.38B
Change in Other Net Operating Assets	248M	472M	2.34B	784M	1.92B
Cash from Operations	-3.33B	226M	15.22B	7B	2.42B
Capital Expenditure	-4.14B	-4.7B	-3.22B	-6.54B	-8.45B
Sale of Property, Plant, and Equipment	-	-	-	-	3.1B
Cash Acquisitions	-	-2.03B	-	-1.28B	-84M
Divestitures	-	-	-	235M	-
Sale (Purchase) of Intangible assets	-125M	-86M	-219M	-550M	-205M
Investment in Marketable and Equity Securities, Total	882M	-596M	605M	3.17B	2.21B
Net (Increase) Decrease in Loans Originated / Sold - Investing	20M	-4M	-	-	-
Other Investing Activities, Total	101M	375M	216M	264M	209M
Cash from Investing	-3.26B	-7.04B	-2.62B	-4.7B	-3.22B
Short Term Debt Issued, Total	3.43B	7.38B	-	1.67B	10.71B
Long-Term Debt Issued, Total	4.19B	6.78B	3.61B	2.76B	3.56B
Total Debt Issued	7.62B	14.16B	3.61B	4.43B	14.27B
Short Term Debt Repaid, Total	-	-	-15.71B	-1M	-2B
Long-Term Debt Repaid, Total	-6.05B	-6.68B	-5.25B	-6.4B	-6.11B
Total Debt Repaid	-6.05B	-6.68B	-20.96B	-6.41B	-8.11B
Issuance of Common Stock	5.49B	-	-	45M	23M
Repurchase of Common Stock	-	-	-	-450M	-
Common Dividends Paid	-1.14B	-1.63B	-1.66B	-1.82B	-2.56B
Common & Preferred Stock Dividends Paid	-1.14B	-1.63B	-1.66B	-1.82B	-2.56B
Other Financing Activities, Total	-165M	45M	-270M	-595M	-288M
Cash from Financing	5.76B	5.9B	-19.28B	-4.8B	3.34B
Foreign Exchange Rate Adjustments	87M	791M	594M	562M	485M
Miscellaneous Cash Flow Adjustments	681M	3M	1M	-1M	-
Net Change in Cash	-58M	-129M	-6.09B	-1.94B	3.03B
Supplemental Items
Cash Interest Paid	512M	838M	1.11B	981M	1.06B
Cash Income Tax Paid (Refund)	2.01B	4.94B	2.67B	1.89B	3.66B
Levered Free Cash Flow	-10.62B	-6.27B	13.61B	-1.31B	-4.57B
Unlevered Free Cash Flow	-10.29B	-5.75B	14.29B	-702M	-3.91B
Change In Net Working Capital	17.05B	11.06B	-9.53B	2.75B	6.12B
Net Debt Issued / Repaid	1.57B	7.48B	-17.35B	-1.98B	6.16B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.25	2.85	1.82	2.28	2.91
Return on Total Capital	6.22	4.13	2.66	3.52	4.61
Return On Equity %	15.08	9.2	2.55	7.13	7.55
Return on Common Equity	15.06	9.19	2.49	7.09	7.52
Margin Analysis
Gross Profit Margin %	16.49	14.06	13.11	13.21	13.94
SG&A Margin	8.52	9.32	10	9.7	9.46
EBITDA Margin %	9.7	7.43	5.86	5.96	6.61
EBITA Margin %	7.46	5.2	3.32	3.68	4.6
EBIT Margin %	7.05	4.71	3.12	3.51	4.43
Income From Continuing Operations Margin %	4.86	3.11	0.94	2.47	2.58
Net Income Margin %	4.8	3.08	0.91	2.44	2.55
Net Avail. For Common Margin %	4.8	3.08	0.91	2.44	2.55
Normalized Net Income Margin	4.35	2.84	1.92	2.35	2.64
Levered Free Cash Flow Margin	-6.79	-3.52	7.78	-0.66	-2.08
Unlevered Free Cash Flow Margin	-6.58	-3.22	8.17	-0.36	-1.78
Asset Turnover
Asset Turnover	0.96	0.97	0.93	1.04	1.05
Fixed Assets Turnover	6.52	6.25	5.49	5.7	5.72
Receivables Turnover (Average Receivables)	2.9	2.96	2.97	3.32	3.38
Inventory Turnover (Average Inventory)	3.73	3.29	3.08	3.23	3.06
Short Term Liquidity
Current Ratio	1.43	1.44	1.48	1.4	1.35
Quick Ratio	0.9	0.88	0.87	0.79	0.74
Operating Cash Flow to Current Liabilities	-0.04	0	0.17	0.07	0.02
Days Sales Outstanding (Average Receivables)	125.98	123.27	123.29	109.83	108
Days Outstanding Inventory (Average Inventory)	97.78	110.82	118.75	112.84	119.17
Average Days Payable Outstanding	96.02	96.78	103.29	100.48	103.73
Cash Conversion Cycle (Average Days)	127.74	137.31	138.76	122.18	123.43
Long Term Solvency
Total Debt/Equity	107.79	113.92	83.19	76.43	75.4
Total Debt / Total Capital	51.87	53.25	45.41	43.32	42.99
LT Debt/Equity	32.88	33.16	27.62	21.55	16.85
Long-Term Debt / Total Capital	15.82	15.5	15.08	12.21	9.61
Total Liabilities / Total Assets	67.51	67.14	63.72	64.24	64.06
EBIT / Interest Expense	21.24	9.99	4.97	7.11	9.3
EBITDA / Interest Expense	29.2	15.77	9.33	12.06	13.85
(EBITDA - Capex) / Interest Expense	21.23	10.17	6.39	5.34	5.79
Total Debt / EBITDA	4.08	5.42	5.38	4.58	4.15
Net Debt / EBITDA	2.32	3.38	3.29	2.98	2.67
Total Debt / (EBITDA - Capex)	5.61	8.41	7.85	10.35	9.94
Net Debt / (EBITDA - Capex)	3.19	5.25	4.8	6.74	6.39
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-27.3	14.11	-1.92	12.64	11.53
Gross Profit, 1 Yr. Growth %	38.74	-2.68	-8.59	13.52	17.7
EBITDA, 1 Yr. Growth %	58.91	-12.6	-22.6	14.45	23.74
EBITA, 1 Yr. Growth %	86.46	-20.52	-37.41	25.06	39.41
EBIT, 1 Yr. Growth %	96	-23.84	-34.91	26.65	40.81
Earnings From Cont. Operations, 1 Yr. Growth %	162.17	-27.08	-70.21	195.33	16.42
Net Income, 1 Yr. Growth %	162.48	-26.89	-70.88	200.69	16.5
Normalized Net Income, 1 Yr. Growth %	93.36	-25.5	-33.76	38.37	25.01
Diluted EPS Before Extra, 1 Yr. Growth %	148.75	-35.44	-70.91	200.32	17.01
Accounts Receivable, 1 Yr. Growth %	19.67	4.94	-8.96	11.13	8.36
Inventory, 1 Yr. Growth %	66.22	13.14	-0.36	14.78	18.55
Net Property, Plant and Equip., 1 Yr. Growth %	9.7	27.66	-0.8	17.76	5.42
Total Assets, 1 Yr. Growth %	19.28	8.76	-4.69	7.51	13.12
Tangible Book Value, 1 Yr. Growth %	40.31	12.66	6.62	6.46	14.84
Common Equity, 1 Yr. Growth %	32.71	9.94	5.16	6.01	13.71
Cash From Operations, 1 Yr. Growth %	-181.23	-106.79	6.63K	-53.97	-65.39
Capital Expenditures, 1 Yr. Growth %	45.8	13.76	-31.46	102.85	29.27
Levered Free Cash Flow, 1 Yr. Growth %	-2.23K	-40.89	-316.84	-109.63	248.52
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.4K	-44.13	-348.58	-104.91	457.12
Dividend Per Share, 1 Yr. Growth %	23.81	3.85	1.85	34.55	17.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-17.97	-8.92	5.79	5.1	12.08
Gross Profit, 2 Yr. CAGR %	17.63	16.2	-5.68	1.87	15.59
EBITDA, 2 Yr. CAGR %	30.86	17.85	-17.75	-5.88	19
EBITA, 2 Yr. CAGR %	41.77	21.73	-29.47	-11.52	32.04
EBIT, 2 Yr. CAGR %	45.91	22.18	-29.59	-9.2	33.54
Earnings From Cont. Operations, 2 Yr. CAGR %	45.45	38.26	-53.39	-6.2	85.42
Net Income, 2 Yr. CAGR %	44.07	38.52	-53.86	-6.43	87.17
Normalized Net Income, 2 Yr. CAGR %	43.74	20.02	-29.75	-4.27	31.52
Diluted EPS Before Extra, 2 Yr. CAGR %	40.45	26.72	-56.67	-6.54	87.46
Accounts Receivable, 2 Yr. CAGR %	16.18	12.07	-2.25	0.59	9.73
Inventory, 2 Yr. CAGR %	29.34	37.14	6.17	6.94	16.65
Net Property, Plant and Equip., 2 Yr. CAGR %	9.49	18.34	12.53	8.08	11.42
Total Assets, 2 Yr. CAGR %	14.55	13.9	1.81	1.23	10.28
Tangible Book Value, 2 Yr. CAGR %	24.2	25.73	9.6	6.54	10.57
Common Equity, 2 Yr. CAGR %	18.47	20.79	7.52	5.58	9.79
Cash From Operations, 2 Yr. CAGR %	-39.49	-76.52	113.79	456.66	-60.09
Capital Expenditures, 2 Yr. CAGR %	14.92	28.79	-11.7	17.91	61.93
Levered Free Cash Flow, 2 Yr. CAGR %	22.55	255.19	13.21	-54.31	-42.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.03	169.38	17.85	-65.06	-47.69
Dividend Per Share, 2 Yr. CAGR %	11.27	13.39	2.84	17.06	25.77
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-15.33	-8.43	-6.65	8.02	7.2
Gross Profit, 3 Yr. CAGR %	10.29	10.43	7.26	0.33	6.89
EBITDA, 3 Yr. CAGR %	17.56	14.39	2.44	-8.18	3.11
EBITA, 3 Yr. CAGR %	19.55	16.9	-2.48	-14.63	2.95
EBIT, 3 Yr. CAGR %	20.76	17.48	-0.95	-14.37	5.1
Earnings From Cont. Operations, 3 Yr. CAGR %	22.83	15.55	-17.11	-13.75	0.81
Net Income, 3 Yr. CAGR %	23.26	14.91	-17.64	-13.82	0.66
Normalized Net Income, 3 Yr. CAGR %	22.86	15.46	-1.55	-11.94	4.64
Diluted EPS Before Extra, 3 Yr. CAGR %	22.11	8.39	-22.41	-17.38	0.73
Accounts Receivable, 3 Yr. CAGR %	8.23	12.31	4.57	2.02	3.11
Inventory, 3 Yr. CAGR %	13.74	23.7	23.29	8.97	10.68
Net Property, Plant and Equip., 3 Yr. CAGR %	10.05	15.24	11.58	14.25	7.19
Total Assets, 3 Yr. CAGR %	7.04	12.59	7.33	3.68	5.05
Tangible Book Value, 3 Yr. CAGR %	20.04	20.23	19	8.54	9.24
Common Equity, 3 Yr. CAGR %	14.47	15.56	15.34	7.02	8.23
Cash From Operations, 3 Yr. CAGR %	-14.25	-70.81	54.85	28.13	120.53
Capital Expenditures, 3 Yr. CAGR %	18.85	14.53	4.37	16.51	21.58
Levered Free Cash Flow, 3 Yr. CAGR %	454.54	-3.89	201.31	-50.21	-10.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	205.69	-8.53	162.26	-59.14	-12.05
Dividend Per Share, 3 Yr. CAGR %	10.06	8.74	9.41	12.48	17.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5	-6.38	-7.44	-3.24	0.44
Gross Profit, 5 Yr. CAGR %	12.22	5.66	3.6	6.92	10.52
EBITDA, 5 Yr. CAGR %	19.22	5.7	1.91	5.8	8.77
EBITA, 5 Yr. CAGR %	20.11	3.32	-3.2	4.57	10.09
EBIT, 5 Yr. CAGR %	21.46	2.76	-2.68	5.98	11.62
Earnings From Cont. Operations, 5 Yr. CAGR %	18.88	0.2	-16.64	6.3	14.39
Net Income, 5 Yr. CAGR %	19.48	0.56	-16.8	5.84	14.38
Normalized Net Income, 5 Yr. CAGR %	21.14	1.47	-1.76	7.12	10.54
Diluted EPS Before Extra, 5 Yr. CAGR %	18.76	-2.42	-19.32	2.15	10.42
Accounts Receivable, 5 Yr. CAGR %	6.62	5.44	3.91	7.46	6.6
Inventory, 5 Yr. CAGR %	17.56	15.47	10.65	16.7	20.59
Net Property, Plant and Equip., 5 Yr. CAGR %	18.78	16.65	11.04	12.32	11.52
Total Assets, 5 Yr. CAGR %	9.2	8	4.92	7.9	8.5
Tangible Book Value, 5 Yr. CAGR %	16.79	15.08	15.75	14.55	15.56
Common Equity, 5 Yr. CAGR %	11.91	11.17	11.64	11.46	13.09
Cash From Operations, 5 Yr. CAGR %	88.47	-39.76	23.58	-5.09	-9.97
Capital Expenditures, 5 Yr. CAGR %	18.91	19.09	5.53	15.87	24.41
Levered Free Cash Flow, 5 Yr. CAGR %	32.83	22.06	193.71	-28.62	55.8
Unlevered Free Cash Flow, 5 Yr. CAGR %	34.34	23.56	108.79	-37.76	37.62
Dividend Per Share, 5 Yr. CAGR %	18.77	11.03	7.12	11.99	15.68